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Abstract
Objective Clinical hepatic diffusion weighted imaging
(DWI) generally relies on mono-exponential diffusion.
The aim was to demonstrate that mono-exponential
diffusion in the liver is contaminated by microperfusion
and that the bi-exponential model is required.
Methods Nineteen fasting healthy volunteers were exam-
ined with DWI (seven b-values) using fat suppression and
respiratory triggering (1.5 T). Five different regions in the
liver were analysed regarding the mono-exponentially fitted
apparent diffusion coefficient (ADC), and the bi-
exponential model: molecular diffusion (Dslow), micro-
perfusion (Dfast) and the respective fractions (fslow/fast). Data
were compared using ANOVA and Kruskal–Wallis tests.
Simulations were performed by repeating our data analyses,
using just the DWI series acquired with b-values approx-
imating those of previous studies.
Results Median mono-exponentially fitted ADCs varied sig-
nificantly (P<0.001) between 1.107 and 1.423×10−3 mm2/s
for the five regions. Bi-exponential fitted Dslow varied between
0.923 and 1.062×10−3 mm2/s without significant differences
(P=0.140). Dfast varied significantly, between 17.8 and 46.8×
10−3 mm2/s (P<0.001). F-tests showed that the diffusion data
fitted the bi-exponential model significantly better than the
mono-exponential model (F>21.4, P<0.010). These results
were confirmed by the simulations.
Conclusion ADCs of normal liver tissue are significantly
dependent on the measurement location because of sub-
stantial microperfusion contamination; therefore the bi-
exponential model should be used.
Key Points
& Diffusion weighted MR imaging helps clinicians to
differentiate tumours by diffusion properties
& Fast moving water molecules experience microperfusion,
slow molecules diffusion
& Hepatic diffusion should be measured by bi-exponential
models to avoid microperfusion contamination
& Mono-exponential models are contaminated with micro-
perfusion, resulting in apparent regional diffusion differences
& Bi-exponential models are necessary to measure diffusion
and microperfusion in the liver
Keywords Diffusion weighted imaging . IVIM . Liver
parenchyma .Microperfusion . ADC variability
Introduction
Diffusion weighted imaging (DWI) started with the
introduction of intravoxel incoherent motion (IVIM) imag-
ing by Le Bihan et al. in the late 1980s [1]. IVIM was
developed to quantify microscopic translational motions in
a voxel by defining the apparent diffusion coefficient
(ADC), which integrates the effects of both molecular
diffusion and microperfusion of blood in the capillary
network [2]. The ADC is sensitive to all intravoxel
incoherent motions and equals the diffusion coefficient
Dslow if only molecular diffusion is present. However,
ADCs of brain tissue were often higher than expected
because of microperfusion contamination. Therefore, the
IVIM theory was extended to a bi-exponential model that
was used to obtain pure and separate images of molecular
diffusion Dslow and microperfusion Dfast [3]. DWI was
introduced in the abdominal organs from the early 1990s
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[4]; before that, it was primarily limited to the brain [1–3,
5]. Subsequently, DWI of liver parenchyma and liver
abnormalities was performed, however mainly by applica-
tion of ADC quantification using the mono-exponential
model [6–8]. Yamada et al. then demonstrated that the
effect of microperfusion significantly contributes to the
ADCs of abdominal organs and hepatic lesions [9]. They
concluded by application of the bi-exponential model that
the molecular diffusion coefficient Dslow and microperfu-
sion fraction f are useful parameters for the characterisation
of hepatic lesions. This was supported by later studies that
showed the additional value of using the bi-exponential
model for the clinical evaluation of hepatic parenchyma and
hepatic lesions [10–14].
However, we noticed that most liver studies up to
now rely on the ADC as a measure for molecular
diffusion without taking into account microperfusion
contamination [15–17]. Only a few liver studies avoided
microperfusion contamination by choosing only higher b-
values starting from 50 mm2/s for the calculation of ADCs
[18–23]. Others showed that besides the MRI technique
and field strength, the location of the measurement can
influence the ADC significantly [21, 24–26]. We, howev-
er, suspected that the variation of ADCs in different
regions of the liver was due to microperfusion contami-
nation. Thus, the purpose of this study was to demonstrate
that mono-exponential diffusion in the liver is contami-




The protocol of the study was approved by the
hospital’s institutional review board, and informed
consent was obtained from all subjects. The study
population comprised 10 men and 9 women (n=19)
ranging from 20 to 62 years old (mean 32.9 years). All
subjects were healthy volunteers, without relevant medical
history, with a body mass index (BMI) ranging from 20 to
32 kg/m2. The only preparation before the examination
was an 8-h fasting period.
MR protocols
All subjects were prospectively examined using MR
imaging at 1.5 T (Magnetom Avanto, Siemens Medical
Solutions, Erlangen, Germany). The body coil served as a
transmitter and a six element spine matrix coil in
combination with the body matrix as a receiver. After
routine localiser- and T2-weighted imaging a series (b=0,
50, 100, 250, 500, 750, 1000 s/mm2) of isotropic diffusion
weighted images (DWI) were acquired using a spin echo
based echo-planar imaging (EPI) sequence in combination
with spectral adiabatic inversion recovery (SPAIR) fat
suppression. The acquisition was gated using PACE
respiratory triggering (TR=3100–6500 ms) and was tuned
with the following parameters: TE 75 ms; slice-thickness
6 mm; slice-gap 18 mm; FOV 379×284 mm; matrix 192×
144; bandwidth 1735 Hz/pixel; averages 2 and parallel
acquisition technique GRAPPA with acceleration factor 2.
Diffusion gradients (25 mT/m) were applied in the phase,
read, and z-directions separately. In total 9 transverse slices
were acquired with an 18 mm slice gap to cover the whole
liver within an average total acquisition time of 8.1 min
(range; 4.7–11.1 min). The image acquisition took place in
an interleaved mode; first slices 1, 4 and 7 were
consecutively acquired with b=0 value, then the same
slices with b=50 value and so on up to b=1000.
Subsequently, slices 2, 5 and 8 were acquired in the same
way, and finally slices 3, 6 and 9 also.
Image analysis
A programmable graphical and calculus environment
was used (Matlab, The Mathworks, Natick, MA, USA)
to develop a tool for analysing the DWI series using
mono- and bi-exponential fitting procedures. First, the
DWI data were loaded and the five liver regions were
defined for all 19 datasets by drawing circular regions-
of-interest (ROIs) with a diameter of 22.3 mm on
selected transverse 6-mm slices (Fig. 1). For each dataset
three slices at three different levels were selected; medial
at the level of the right portal vein, cranial above the level
of the left portal vein and caudal at the level of the splenic
vein. The first three regions were drawn in the medial liver
slice: central in the right lobe (ROI 1, segments 5/8),
dorso-lateral in the right lobe (ROI 2, segments 6/7) and
ventral in the left lobe (ROI 3, segments 2/3). The fourth
region was drawn in the cranial liver slice, dorso-lateral in
the right lobe (ROI 4, segment 7), and the last region in
the caudal liver slice, near the gallbladder (ROI 5, segment
5). Any nearby visible vascular and biliary structures were
avoided. For each ROI and all seven b-values the average
signal intensity S was calculated and stored. Then, the
signal intensities S and all seven b-values were fitted to
the bi-exponential model [3]:
S
S0
¼ ffast  expðb  DfastÞ þ fslow  expðb  DslowÞ ð1Þ
where S0 is the maximum signal intensity, Dfast is the fast
component representing microperfusion, ffast is the frac-
tion of microperfusion, Dslow is the slow component
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representing molecular diffusion and fslow is the fraction of
molecular diffusion (fslow=1 - ffast). Equation 1 was fitted
by the Nelder-Mead simplex direct search method with
bound constraints (Table 1), which performs a constrained
non-linear minimisation of the sum of the squared
residuals [27, 28]. Finally, the conventional ADC was
determined using linear regression analysis of the natural
log of signal intensities S versus all seven b-values [2]:
S ¼ A expðb  ADCÞ ð2Þ
where A is the intercept of the signal.
Parametric maps
For one subject, parametric maps of ADC and Dslow were
calculated by fitting the diffusion signal of a 4 by 4 pixels
area to the mono- and bi-exponential model. The area was
then moved 4 pixels until the whole liver matrix (192×144)
was covered, resulting in a parametric map of 48×36.
Subsequently, the parametric map was rescaled to the
original matrix size by linear interpolation.
Influence of blood vessels
To illustrate the effects of microperfusion on the mono- and
bi-exponential models, an ROI was drawn in one subject
and blood vessels were included in the ROI. Then the same
ROI was moved slightly until the blood vessels were
excluded from the ROI. In both cases ADC, Dslow, Dfast and
f were calculated and the curves presented in a figure for
comparison.
Simulation study
A systematic literature search was performed in order to
compare our results with previous findings. We includ-
ed multi-region DWI liver studies that determined the
ADC for healthy liver tissue for at least 20 patients and
published a P-value for the significance of the ADC
difference among the regions. Then the results of the
reviewed studies were simulated by performing mono-
and bi-exponential analyses on our data using the b-
values and regions mentioned in the review studies. The
ADC, Dslow, Dfast, fslow and ffast resulting from the
simulation were then compared with those of the reviewed
studies.
Statistical analysis
Statistical analysis was performed using SPSS (SPSS 18,
Chicago, IL, USA). All data were tested for normality using
Shapiro–Wilk tests. For normally distributed data (ADC
and Dslow) one-way ANOVA tests were used to compare
measurements between different liver regions. For non-
normally distributed data (Dfast and f) the differences
between liver regions were determined using non-
parametric Kruskal–Wallis tests. The central tendency and
variability of the data were quantified by the median m1=2
and the median deviation s1=2 [29] where
s1=2 ¼ medianðjxi  m1=2jÞ ð3Þ
For each individual fitting procedure the coefficient
of correlation (goodness-of-fit) R2 was adjusted for
Fig. 1 Diffusion in the liver was measured in five locations (ROI 1 to
5) with a diameter of 22.3 mm. a Transverse plane of the medial liver
with ROI 1 central in the right lobe (segments 5/8), ROI 2 dorso-
lateral in the right lobe (segments 6/7) and ROI 3 ventral in the left
lobe (segments 2/3). b Transverse plane of the cranial liver with ROI 4
dorso-lateral in the right lobe (segment 7) c Transverse plane of the
caudal liver with ROI 5 near the gallbladder (segment 5)
Table 1 Fitting parameters
aNumber of parameters
Bi-exponential fit (p=3)a Lower-bound Higher-bound Initial guess
ffast (unitless) 1e-8 1 0.4
Dfast (×10
−3 mm2/s) 1e-5 100 10
Dslow (×10
−3 mm2/s) 1e-5 10 1
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the number of parameters p and the number of data points
n:
R2adj ¼ 1
ð1 R2Þ  ðn 1Þ
n p ð4Þ
where n=7 for seven b-values and p=2 or 3 for mono-
and bi-exponential models respectively. F-tests were
performed to evaluate whether the bi-exponential model
was justified over a mono-exponential model:
F ¼ ðSSEmono  SSEbiÞ=ðDFmono  DFbiÞ
SSEbi=DFbi
ð5Þ
where SSEmono and SSEbi are the sum-of-squared errors
(SSE) of the mono- and bi-exponential fits respectively,
and DFmono and DFbi are the degrees of freedom of both
analyses (DF=n – p). All statistical analyses had a
significance level of 5%.
Results
The mono-exponentially fitted ADCs were significantly
different (P<0.001) among the five regions and normally
distributed (Tables 2 and 3). The left lobe showed the
highest ADC (1.423×10−3 mm2/s) and the lowest ADC
was found centrally in the medial right lobe (1.107×
10−3 mm2/s).
The bi-exponentially fitted Dslow was not shown to be
significantly different (P=0.140) among the five regions
and were normally distributed (Tables 2 and 3). The median
of the Dslow components varied between 0.923 and 1.062×
10−3 mm2/s for each of the five regions.
The bi-exponentially fitted Dfast was significantly differ-
ent (P<0.001) between the five regions and non-normally
distributed (Tables 2 and 3). The median of the Dfast
components varied between 17.8 and 46.8×10−3 mm2/s for
the five regions.
The left lobe showed the highest fraction of micro-
perfusion ffast (47%) and the lowest fraction of diffusion
fslow (53%). The dorso-lateral right lobe showed the lowest
fraction of microperfusion ffast (24%) and the highest
fraction of molecular diffusion fslow (76%). The fslow and
ffast fractions were significantly different among the five
regions (P<0.001) (Table 3).
The adjusted R2 showed that the bi-exponential model
fitted better to the diffusion data than the mono-exponential
model for each liver region (Radj, bi
2>Radj, mono
2). Further-
more, the F-tests showed that the diffusion data fitted
significantly better to the bi-exponential model (F>21.4,
P<0.010) than to the mono-exponential model in all
individual fitting procedures.
Parametric maps
Diffusion weighted imaging data of the medial liver of one
subject were used to calculate ADC and Dslow maps
(Fig. 2). The Dslow map showed a more homogeneous
distribution of the bi-exponential fitted slow diffusion
throughout the liver. The ADC map showed more differing
values between different regions of the liver, especially near
blood vessels and in the left lobe.
Influence of blood vessels
In one subject, the effects of microperfusion on the mono-
and bi-exponential models were illustrated by including
blood vessels in the ROI; this showed a large influence of
microperfusion on the ADC (Fig. 3). When the blood
vessels were excluded from the ROI a decreased ADC was
observed. However, Dslow was similar to when blood
vessels were included in the ROI.
Simulation study
The systematic literature search resulted in six multi-region
DWI studies of the liver in which a minimal of 20 patients
were included and in which between two and four different
regions of healthy liver parenchyma were analysed [13, 19,
21, 25, 26, 30]. Studies in which mono-exponential
analyses were performed showed ADCs between 1.00 and
2.69×10−3 mm2/s using sets of two, three or five b-value
combinations between 0 and 1300 s/mm2 (Table 4). We
found ADCs between 0.94 and 2.39×10−3 mm2/s when
using the same b-value combinations. All mono-
exponential studies reported significantly (P<0.05) differ-
ent ADCs between the different liver regions, this was
confirmed by our simulation study (P<0.001).
In one study a bi-exponential analysis of two different
regions of liver parenchyma was performed using a series
of ten b-values between 0 and 800 s/mm2 (Table 5) [13].
They did not find significantly different Dslow components
among different liver regions (P=0.5); this was confirmed
by our simulation study (P=0.105).
Table 2 Tests of normality
Region Segment ADC Dslow Dfast fslow/fast
1 5/8 0.798 0.929 0.022* 0.761
2 6/7 0.895 0.708 0.086 0.005*
3 2/3 0.814 0.309 0.007* 0.900
4 7 0.208 0.523 0.563 0.023*
5 5 0.230 0.735 0.167 0.663
P values (Shapiro–Wilk tests) indicate deviations from normal
distribution (P<0.05). Measurements of Dfast and f fractions were
non-normally distributed, Dslow values were normally distributed
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Discussion
The aim of this study was to demonstrate that mono-
exponential diffusion in the liver is contaminated by
microperfusion. We suspected that variation of ADCs in
different regions of the liver is due to microperfusion
contamination and that therefore the bi-exponential model
is required. We found that the ADC of normal liver tissue is
substantially dependent on the location; however, the bi-
exponentially fitted Dslow is not dependent on the location
of the measurement. We used terminology according to the
suggestions of Guiu and Cercueil who convincingly
advocated for the use of Dslow to describe molecular
diffusion properties and Dfast to describe microperfusion
[31].
Our results agree with earlier studies reporting signifi-
cant differences among ADCs obtained in different regions
in the liver [19, 21, 25, 26, 30]. ADCs in our study (1.107
to 1.423×10−3 mm2/s) were consistent with those of
previous reports, which showed a large range (0.69 to
2.69×10−3 mm2/s) of ADCs for normal liver tissue [15, 25,
32]. The results on Dslow were supported by Luciani et al.;
they also found no significant differences between Dslow of
normal liver tissue [13]. They found that Dslow varied
between 1.02 and 1.16×10−3 mm2/s; this is comparable to
our range (0.98 to 1.18×10−3 mm2/s) when we simulated
their results using our data and similar b-values.
The demonstrated regional dependence of the ADC
contrary to the non-regional dependence of Dslow can be
explained from the differences between the mono- and the
bi-exponential models. The mono-exponentially fitted ADC
is to a high degree sensitive to microperfusion, which was
already shown by Le Bihan et al. in the brain [2]. When the
DWI sequence contains b-values in the microperfusion
range, and the microperfusion is relatively high compared
with the diffusion component, then the model will result in
a high ADC compared with Dslow. When there is no
microperfusion, which has been reported for fibroglandular
breast tissue, the ADC will be comparable to Dslow [33].
Hence the ADC of the liver is to a large extent dependent
Fig. 2 An example of ADC and Dslow maps of the medial liver. a
ADC map (left) and Dslow map (right) of the medial liver which were
scaled equally from 0.1×10−3 to 2×10−3 mm2/s. The Dslow map shows
a more homogeneous distribution of the bi-exponential fitted slow
diffusion component throughout the liver. The ADC map shows
significantly different values between different regions of the liver,
especially near blood vessels and in the left lobe. b The anatomical
position of the ADC and Dslow maps
Table 3 Mono- and bi-exponential fitting results for five regions in the liver
Mono-exponential fit Bi-exponential fit
Radj
2≥0.479 Radj2≥0.969
Region Segment ADC (×10−3 mm2/s) ffast (%) Dfast (×10
−3 mm2/s) fslow (%) Dslow (×10
−3 mm2/s)
1 5/8 1.107±0.101 29±5 33.5±12.1 71±5 0.923±0.148
2 6/7 1.204±0.055 24±3 37.8±11.0 76±3 1.038±0.052
3 2/3 1.423±0.118 47±9 17.8±7.1 53±9 0.900±0.228
4 7 1.239±0.090 24±5 46.8±19.8 76±5 1.062±0.118
5 5 1.107±0.102 29±4 43.6±9.7 71±4 0.954±0.120
P-value <0.001* <0.001† <0.001† <0.001† 0.140*
Data are medians ± median absolute deviations. Both mono- and bi-exponential fits were determined with seven b-values (0, 50, 100, 250, 500,
750 and 1000). Radj
2 is the goodness-of-fit correlation coefficient. P values indicate the significance of differences between different regions in the
liver. *One-way ANOVA. †Non-parametric Kruskal–Wallis
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on microperfusion, especially when the DWI sequence
contains several b-values in the microperfusion range [14].
This is why in some studies researchers tried to choose b-
values not within the microperfusion range [18–23]. For
example, Perman et al. observed that the ADC value for
liver decreased from 1.36 to 0.98×10−3 mm2/s when the b=
0 value was omitted; this is similar to the range of Dslow that
we found. In a recent consensus report on DWI, it was
recommended to use two b-values (>100 and between 500
and 1000 mm2/s) for ADC assessments [34]. It is, however,
difficult to choose b-values such that microperfusion
contamination of the ADC is avoided, because the micro-
perfusion effects of the tissue are not known beforehand.
We demonstrated in our simulation study that, although low
b-values were excluded, the ADC of liver tissue was to a
large extent contaminated by microperfusion and that this
resulted in apparent differences of the diffusion between
liver regions. The simulation study also showed that the
variety of ADC values of healthy liver tissue published in
the literature, were probably caused by the choice of b-
values, and the mono-exponential model itself. This is a
pitfall of using the ADC as a measure for molecular
diffusion; there is no optimal combination of b-values,
because the amount of microperfusion determines the
optimal sequence of b-values and this is not known a
priori. Recently, a similar simulation study was performed
in the kidneys; they also found that the variability of the
ADC in the kidneys is caused by the use of the mono-
exponential model [35].
The microperfusion component Dfast of the bi-
exponential model significantly depends on the location of
the measurement. This contradicts with the results of
Fig. 3 An example of the
effects of microperfusion on
DWI measurements. To illus-
trate the effects of microperfu-
sion on the mono- and bi-
exponential model, blood ves-
sels were included in the ROI
(left) which showed a large
influence of microperfusion on
the ADC. Then the same ROI
was moved slightly until the
blood vessels were excluded
from the ROI (right) which
showed a decreased ADC, how-
ever Dslow was similar to when
blood vessels were included in
the ROI. The noise was defined
as the average signal measured
in air (green ROI), away from
any visible artefacts
Table 4 Reviewed data simulated with mono-exponential analysis
Reviewed data Simulated on our data
Ref. n b-values (s/mm2) #regions ADC (range) P value b-values (s/mm2) ADC (range) P value
Nasu et al. [25] 30 0, 500 2 1.98–2.69 <0.001 0, 500 1.64–2.39 <0.001
Yoshikawa et al. [30] 45 0, 600 4 1.55–1.63 <0.05† 0, 750 1.38–1.91 <0.001
Kiliçkesmez et al. [26] 50 0, 500 ,600 4 1.34–1.77 <0.01 0, 500, 750 1.42–1.98 <0.001
Bruegel et al. [21] 90 50, 300, 600 4 1.12–1.44 <0.001 50, 250, 750 1.02–1.41 <0.001
Mürtz et al. [19] 36 50, 300, 700, 1000, 1300 3 1.00–1.16 <0.05† 50, 250, 750, 1000 0.94–1.10 (only RL)a 0.001
ADCs are means in units of 10−3 mm2 /s. P values (one-way ANOVA) indicate the significance of differences between different regions in the
liver. †P value was not mentioned; however the significance level was 5%. aMürtz et al. [19] did not evaluate regions in the left lobe; therefore we
excluded ROI 3 (left lobe) from the simulation
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Luciani et al., who did not find a location dependency of
Dfast, possibly because they compared just two regions (left
and right lobe) [13]. The range (71.0–85.1×10−3 mm2/s)
was higher than what we found (27.9–57.2×10−3 mm2/s)
when we simulated their results using our data and similar
b-values. This may reflect the use of different calculation
methods. In our study f, Dfast and Dslow of an ROI were
calculated by taking the medians of the underlying b-maps
as an input for the fitting procedure, where Luciani et al.
first calculated Dfast, Dslow and f maps on a pixel-by-pixel
based fitting procedure, after which the average of an ROI
was calculated. In addition, they used six b-values under
100 s/mm2 (versus two in our study), which tends to
decrease the uncertainty of the fitting algorithm, and
increase the slope of the curve close to zero. This might
explain the higher Dfast and the decreased range of Dfast in
their study. However, we have shown that even with seven
(rather than 16 b-values) the bi-exponential fits are already
extremely accurate, which is supported by the nearly
identical values of Dslow in their study and our simulation
study. Too little b-values under b=100 s/mm2 can however
hamper an accurate determination of Dfast, especially when
analysing tissues with high Dfast values, which can be
expected in pathology or near blood vessels.
The increase in the ADC in the left lobe, which was
demonstrated in Fig. 2, is usually explained from the
increased cardiac motion in the left lobe [19, 25, 36–38].
However, we found that the fraction of microperfusion ffast
in the left lobe was almost a factor two higher than in other
liver locations. Although pseudo-anisotropy is a known
artefact of respiratory triggering in the liver [39], we
suspect that the increased ADC in the left lobe may be
caused by extensive microperfusion contamination of the
ADC and to a lesser extent by either cardiac or respiratory
artefacts. This is supported by a study on the hepatic
perfusion of eight hepatic segments by dual-source com-
puted tomography [40]. They found that the hepatic
perfusion index (HPI) was significantly higher in segment
3 (left lobe) than in segments 5 to 8 (right lobe), and
suggested that this might be related to the anatomy of the
liver vessels. Another study using pharmacokinetic analysis
of dynamic contrast-enhanced MRI demonstrated that
regional variations in liver microcirculation can be dis-
played by colour-coded parameter maps [41]. They found a
minor variation of perfusion in an apical section of a
transplanted liver. The left part of the liver, corresponding
to segment 2, showed a different perfusion rate than the
right part of the liver. In an experimental study on rats using
perfusion CT, the relative blood flow in the left lobe was
17% higher than in the right lobe of the liver [42]. We
suspect that these regional variations in the density of small
blood vessels and capillaries caused the heterogeneous
appearance of microperfusion throughout the liver. This is
supported by our analysis of including a blood vessel in the
ROI, which resulted in more microperfusion contamination
than when blood vessels were avoided.
Some studies have reported on age-related changes in
liver structure and function [43, 44]. However, Pasquinelli
et al. showed no significant variations in liver DWI
quantitative parameters according to the age of the subject
[45]. Therefore, we assumed that the possible effects of age
in our cohort are far smaller than the demonstrated
significant region dependency of the ADC in the liver.
Although the conclusions in this study are drawn from
healthy volunteers, we suspect that the effects of micro-
perfusion are much larger in pathology, and should
therefore be applicable to patient data also.
In conclusion, the ADC of normal liver tissue is
significantly dependent on the measurement location
because of substantial microperfusion contamination; there-
fore the bi-exponential model should be used. Currently, the
diagnostic use of DWI for discriminating hepatic masses,
liver cirrhosis and fibrosis is mainly based on the ADC, and
the discrimination between diseased and healthy tissue may
therefore be hampered [6–8, 15–18, 20, 21, 23, 30, 37, 46].
Thus, the bi-exponential model is essential for the future
development of the clinical diagnostic application of DWI
in the liver.
Table 5 Reviewed data simu-
lated with bi-exponential
analysis
Data are means. P values indi-
cate the significance of differ-
ences between different regions
in the liver. aOne-way ANOVA.
bNon-parametric Kruskal–Wallis
Reviewed data [13] Simulated on our data
N 25 19
b-values (s/mm2) 0, 10, 20, 30, 50, 80,
100, 200, 400, 800
0, 50, 100, 250,
500, 750
#regions 2 5
Mean (range) P value Mean (range) P value
ffast (%) 26–31 0.07 26– 43 0.000
b
Dfast (×10
−3 mm2/s) 71.0–85.1 0.1 27.9–57.2 0.001b
fslow (%) 69–74 0.07 57–74 0.000
b
Dslow (×10
−3 mm2/s) 1.02–1.16 0.5 0.98–1.18 0.105a
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